A Reversal for Icon Plc – Ordinary Shares (NASDAQ:ICLR) Is Near. The Stock Has Decrease in Shorts

ICON Public Limited Company (NASDAQ:ICLR) Logo

The stock of Icon Plc – Ordinary Shares (NASDAQ:ICLR) registered a decrease of 9.12% in short interest. ICLR’s total short interest was 606,700 shares in September as published by FINRA. Its down 9.12% from 667,600 shares, reported previously. With 265,000 shares average volume, it will take short sellers 2 days to cover their ICLR’s short positions. The short interest to Icon Plc – Ordinary Shares’s float is 1.13%.

The stock increased 0.60% or $0.89 during the last trading session, reaching $150.43. About 123,992 shares traded. ICON Public Limited Company (NASDAQ:ICLR) has risen 13.42% since September 13, 2018 and is uptrending. It has outperformed by 13.42% the S&P500.

ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. The company has market cap of $8.14 billion. The firm specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It has a 23.22 P/E ratio. The Company’s clinical development services comprise product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, clinical research center, investigator site, patient recruitment, study monitoring and data collection, case report form preparation, statistical analysis, patient safety and risk monitoring, clinical data management, strategic analysis and data operation, regulatory consulting, and medical reporting and pharmacovigilance services.

ICON Public Limited Company (NASDAQ:ICLR) Ratings Coverage

Among 4 analysts covering ICON (NASDAQ:ICLR), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. ICON has $17100 highest and $148 lowest target. $163.50’s average target is 8.69% above currents $150.43 stock price. ICON had 9 analyst reports since March 15, 2019 according to SRatingsIntel. KeyBanc Capital Markets maintained it with “Overweight” rating and $16500 target in Thursday, August 8 report. On Monday, March 18 the stock rating was maintained by Barclays Capital with “Hold”. On Thursday, July 25 the stock rating was maintained by Mizuho with “Buy”. The rating was upgraded by UBS on Friday, July 26 to “Neutral”.

More notable recent ICON Public Limited Company (NASDAQ:ICLR) news were published by: Nasdaq.com which released: “Icon PLC (ICLR) Beats Q4 Earnings and Revenue Estimates – Nasdaq” on February 20, 2019, also Nasdaq.com with their article: “Icon PLC (ICLR) Tops Q2 Earnings and Revenue Estimates – Nasdaq” published on July 24, 2019, Globenewswire.com published: “MolecularMD is acquired by ICON – GlobeNewswire” on February 21, 2019. More interesting news about ICON Public Limited Company (NASDAQ:ICLR) were released by: Finance.Yahoo.com and their article: “Do You Like ICON Public Limited Company (NASDAQ:ICLR) At This P/E Ratio? – Yahoo Finance” published on September 11, 2019 as well as Businesswire.com‘s news article titled: “ICON plc to Present at Baird’s 2019 Global Healthcare Conference – Business Wire” with publication date: September 03, 2019.

ICON Public Limited Company (NASDAQ:ICLR) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.